Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts.

Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts.

Introduction: Although three randomized control trials have proven mortality benefit of CT lung cancer screening (CTLS), <5% of eligible US smokers are screened. Some attribute this to fear of harm conveyed at shared decision visits, including the harm of overdiagnosis/overtreatment of indolent B...

Full description

Bibliographic Details
Main Authors: Eric J. Burks, Jiarui Zhang, Travis B. Sullivan, Xingyi Shi, Jacob M. Sands, Shawn M. Regis, Brady J. McKee, Andrea B. McKee, Sherry Zhang, Hanqiao Liu, Gang Liu, Avrum Spira, Jennifer Beane, Marc E. Lenburg, Kimberly M. Rieger-Christ
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Low malignant potential adenocarcinoma
Screen
Overdiagnosis
RNA sequencing
CTLS
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294221001829

Internet

http://www.sciencedirect.com/science/article/pii/S2468294221001829

Similar Items